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Abstract The effects of nitric oxide (NO) released from 
zwitterionic polyamine/NO adducts on Cu2+-induced low density 
lipoprotein (LDL) oxidation were studied. When each of the two 
kinds of NO releasing zwitterionic polyamine/NO adducts 
(NOC5 and NOCT) was incubated at 5 laM with isolated human 
LDL (0.25 mg/ml) and Cu 2+, the formation of thiobarbituric acid 
reactive substances (TBARS) was inhibited. The duration of 
inhibition by NOC7 (20 min) and NOC5 (100 min) corresponded 
to the NO generation lives of respective zwitterionic polyamine! 
NO adducts. The duration of inhibition was dependent on the 
amount of NOC5 added (2.5-20 gM). Repeated additions of 
5 ILM NOC5 at 100 min intervals worked as inhibitor in the same 
manner. NOC5 broke to inhibit at any process of the Cu 2+- 
induced LDL oxidation reaction. Fragmentation of apolipopro- 
tein B derived from Cu2+-induced LDL oxidation was also 
prevented by the addition of NOC5. These results clearly 
indicate that NO inhibits the oxidative modification of LDL 
induced by Cu 2+. NO releasing zwitterionic polyamioe/NO 
adducts are good reagents for NO studies. 
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1. Introduction 
Oxidation of low density lipoprotein (LDL) has been re- 
petted to be an important process in the development of 
atherosclerosis [1]. Macrophages target the oxidatively mod- 
ified LDL for uptake and are characterized as foam cells [1]. 
N,~w, endothelium cells are considered to be involved in LDL 
oxidation [l] and nitric oxide (NO) itself may be an endothe- 
livm derived relaxing factor [2]. Endothelium cells and macro- 
phages are known to accelerate LDL oxidation [3-6]. En- 
dethelium cells, macrophages, neutrophils and neuronal cells 
geaerate superoxide (O~-) and NO, which can combine to 
foxn peroxynitrite anion (ONOO)  [7,8]. Synthesized peroxy- 
ni~ rite was shown to induce lipid peroxidation of liposomes 
[9 !. The sydnonimine, SIN-l,  which is known to liberate both 
O " and NO during autoxidation, could initiate lipid peroxi- 
d~ition in human LDL [10] and synthesized peroxynitrite re- 
suited in an increase in electrophoretic mobility of apolipo- 
pr~)tein B in LDL [11]. In contrast, the extent of cell mediated 
oxidative modification of LDL and the generation of high 
uytake LDL was depressed in macrophages active in NO 
s),lthesis [12]. Lipid peroxidation of LDL, as measured by 
th obarbituric acid reactive substances (TBARS), was reduced 
in interferon-,/and tumor necrosis factor-c~ stimulated macro- 
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phages to increase the production of NO [13]. Jessup and 
Dean also reported that NO synthesis of macrophages ap- 
peared to mediate the suppression of LDL oxidation [14,15]. 
Recently, new NO releasing zwitterions have been devel- 
oped [16]. These reagents are known to release NO and 
amines by decomposing by themselves, and do not generate 
any other radicals [16]. On the other hand, macrophages and 
other cells which generate NO are well known to produce 
other reactive oxygen species such as O~. Therefore, these 
zwitterions are useful reagents for studying the effect of NO 
itself on oxidation of LDL. The above facts led us to study 
the effect of NO on cell free oxidation systems. In the present 
study, we investigated the effect of NO released from NO 
releasing zwitterions (NOC5 and NOC7) on Cu ~+ induced 
LDL oxidation by the. determination of TBARS and the frag- 
mentation of apolipoprotein LDL. Our results indicate that 
NO releasing zwitterions inhibited Cu 2+ induced oxidation of 
LDL and these antioxidative effects depended on the range of 
NO generation life of the zwitterions used. 
2. Materials and methods 
2.1. Human LDL preparation 
Human plasma was obtained from volunteers according to the Dec- 
laration of Helsinki. Human LDL (d=l.005 1.065) was prepared by 
the method of Havel et al. [17] and its purity was monitored by two- 
dimensional e ectrophoresis [18]. Isolated LDL was dialyzed against 
20 mM sodium phosphate buffer, pH 7.2, containing 0.15 M sodium 
chloride (PBS) and 2 gM EDTA, overnight at 4°C in the dark. Before 
use, the LDL solution was diluted with 0.1 M sodium phosphate 
buffer, pH 7.2, containing 0.15 M sodium chloride and 0.2 I.tM 
EDTA (PBS-EDTA). The protein concentration f LDL was meas- 
ured with the Bio-Rad protein assay kit (Bio-Rad Laboratories, Rich- 
mond, CA) using bovine serum albumin as a standard. Zwitterionic 
polyamine/NO adducts for releasing NO were as follows: 1-hydroxy- 
2-oxo-3-(3-aminopropyl)-3-isopropyl-l-triazene (NOC5) and 1-hy- 
droxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl- 1-triazene (NOC7) 
(Dojin Chemicals Co., Ltd., Kumamoto, Japan). Epigallocatechin 
gallate (EGCG) was obtained from Kurita Kogyo Ltd. (Tokyo, Ja- 
pan). Butylated hydroxytoluene (BHT) and all the other chemicals 
used were special grade (Wako Pure Chemicals, Tokyo, Japan). 
2.2. LDL oxidation 
LDL (0.25 mg/ml in PBS-EDTA) was incubated at 37°C in the 
presence of 5 /aM CuSO4 and the effects of various zwitterionic 
NO/polyamine adducts were examined. 
2.3. Measurement of LDL oxidation 
A 100 gl aliquot obtained from the reaction mixture very 20 min 
was added to 10 gl of 10 mM EDTA to stop oxidation. Lipid perox- 
idation was estimated fluorometrically as TBARS [19] and/or meas- 
ured by absorbance at 234 nm to detect conjugated iene [20]. In 
TBARS analysis, malondialdehyde (MDA) formed from 1,1,3,3-tetra- 
ethoxypropane was used as a reference standard and the results are 
expressed as nmol equivalents of MDA. We repeated this series of 
experiments wo or three times, and the results showed almost the 
same tendency. Typical results are shown in the figures. 
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2.4. SDS-polyacrylamide g l electrophoresis ( SDS-PA GE ) 
SDS-PAGE for investigating fragmentation of apolipoprotein B in 
LDL by oxidation was performed according to the method of 
Laemmli [21] using a 4-12% gradient gel. The reaction was stopped 
by adding 20 [al of 10 mM EDTA to 200 gl reaction mixture. LDL 
protein was precipitated by adding 200 [al of 50% trichloroacetic a id, 
and recovered by centrifugation at 10000xg for 15 min. The precip- 
itated protein was washed three times with 200 [al of 10 mM phos- 
phate buffer, pH 7.2, and lyophilized. The lyophilized sample was 
dissolved with 15 gl of 10 mM Tris-HC1 buffer, pH 7.2, containing 
2% SDS and 8 M urea, and 10 [ag of protein was applied to SDS- 
PAGE. 
3. Results 
Fig. 1 shows the effects of NOC5 and NOC7 on Cu2+-in - 
duced TBARS formation in LDL. As other antioxidative re- 
agents, 1.5 gM EGCG and 3 p.M BHT were also examined. A
clear prolongation in lag time of accelerative TBARS forma- 
tion was observed. The lag times were as follows: NOC7 20 
min, NOC5 100 min, EGCG 260 min. BHT continued to 
inhibit TBARS formation under the experimental conditions. 
When NOC5 was preincubated in PBS-EDTA for 3 h or more 
at 37°C and then added to LDL oxidation mixture, the in- 
hibitory effect of TBARS formation was not obtained (data 
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Fig. 1. Inhibitory effect of zwitterionic NO/polyamine adducts on 
Cu 2+ induced TBARS formation in LDL. LDL (0.25 mg/ml) was 
dissolved in PBS-EDTA and was incubated with 5 gM CuSO4 at 
37°C (©), in the presence of 5 [aM NOC5 (zx), 5 gM NOC7 (e), 
1.5 [aM EGCG (11) or 3 [aM BHT (x). TBARS formation was 
measured as described in Section 2. 
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Fig. 2. Dose-dependent inhibition of NOC5 on Cu 2+ induced 
TBARS formation in LDL. TBARS formation was measured as de- 
scribed in Fig. 1 with no NOC5 (O), 0.5 (D), 2.5 (e), 5.0 (A), 10.0 
(zx) or 20.0 [aM NOC5 (ll). 
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Fig. 3. Cu 2+ induced apolipoprotein B fragmentation i the pres- 
ence of 5 gM NOC5. LDL (0.25 mg/ml in PBS-EDTA) solution 
was incubated with 5 [aM CuSO4 at 37°C for 0-300 min in the pres- 
ence or absence of 5 gM NOC5. After the incubation, 20 gl of 10 
mM EDTA was added to 200 [al of reaction mixture. Proteins were 
recovered by adding 200 [al of 50% trichloroacetic acid solution and 
washed to lyophilize as described in Section 2. 10 gg of protein was 
applied to SDS-PAGE (4-12% gradient gel). A: With 5 [aM NOC5. 
B: Without NOC5. 
not shown). The inhibitory effects of 0.5, 2.5, 5.0, 10.0 and 
20.0 gM NOC5 on Cu 2+ induced TBARS formation are 
shown in Fig. 2. The lag times to initiate accelerating TBARS 
formation in the presence of 0.5, 2.5, 5.0, 10.0 and 20.0 gM 
NOC5 were 20 min, 80 min, 100 min, 120 min and 180 min, 
respectively. The lag times were dependent on the concentra- 
tions of NOC5 added. Yet, the lag times were not linearly 
prolonged in relation to NOC5 concentration, especially at 
higher concentrations, because of the half-life of NOC5. The 
changes in Cu 2÷ concentration (5-15 gM) had no effect on 
inhibition of TBARS formation by NOC5 (data not shown). 
The results indicate that the chelating effect of NO to Cu 2+ 
and/or trace amounts of transition metals such as iron was 
not related to this inhibiting action. The Cu 2+ induced forma- 
tion of conjugated iene in LDL was also inhibited by the 
addition of NOC5 (data not shown). 
During the time of inhibition of TBARS formation in LDL 
by NOC5 addition, the fragmentation of apolipoprotein B
was also inhibited as shown in Fig. 3A. With the gradual 
oxidative acceleration over 120 min, the original apolipopro- 
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4. Discussion 
L 
Fhe purpose of this study was to observe the possible role 
ot NO generated from NO-releasing zwitterions on Cu 2+ in- 
diced LDL oxidation. Depending on the life time of the zwit- 
te, ions used, the oxidation of LDL measured was inhibited 
(h df-life at 22°C and pH 7.4 in phosphate buffer: NOC7 10.1 
m n, NOC5 93.0 min) [16]. Separate additions of NOC5 were 
m ~re effective than the corresponding amount of NOC5 
a~ded at once (Figs. 2 and 4) and preincubated NOC5 (3 h 
ol more) was without effect (data not shown). These facts 
in ticate that the zwitterions have an inhibitory effect on 
LI)L oxidation depending on the life time of the NO released. 
Endothelial cells and macrophages have been reported to ac- 
ce erate LDL oxidation [3-6]. Various free radicals, such as 
pt roxynitrite anion produced from O~- and NO [7-9] or other 
raJicals such as 0 2 or OH- [22] produced by these cells, 
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F:g. 4. Effect of successive additions of NOC5 on Ca 2+ induced 
T~IARS formation in LDL. After 10 ml of LDL (0.25 mg/ml in 
PBS-EDTA) was incubated with 5 gM CuSO4 in the presence of 
5 gM NOC5 for 100 min, a 2.0 ml aliquot was removed. The re- 
maining solution was further incubated with further addition of 
NOC5 (final concentration 5 gM). The same procedure was 
repeated 3 times every 100 min (indicated with arrows). TBARS for- 
mation was measured as described in Section 2. 
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tein B band had the tendency to diminish and disappear. In 
contrast, as shown in Fig. 3B, without NOC5 addition, the 
fragmentation was apparently accelerated to diminish after 30 
min and disappear over 60 rain. 
Fig. 4 shows the inhibition of Cu 2+ induced TBARS for- 
ma tion in the presence of 5 gM NOC5; it was prolonged with 
emh successive addition of 5 ~tM NOC5 (final concentration) 
ewry 100 min. Four additions of NOC5 every 100 min inhib- 
ite, l TBARS formation continuously for a total of about 420 
mia. As shown in Fig. 2, the inhibitory effect of 20 gM NOC5 
on Cu 2+ induced TBARS formation continued for about 180 
m~l. In contrast, he inhibitory time was prolonged about 2.6- 
fo!cl by four NOC5 additions (corresponding to a total of 20 
gl~I NOC5) every 100 min. The results further confirm that 
th, generation life of NOC5 to release NO was critical to the 
inifibitory action, because of the short life of released NO 
fr~ m the zwitterionic polyamine/NO adducts used. The inhib- 
itory effect of  NOC5 was also obtained in the same manner at 
an¢ time during the process of burst Cu 2+ induced TBARS 
fo mation in LDL as shown in Fig. 5. u~) 6'0 120 180 240 
Incubation t ime(min) 
Fig. 5. The inhibitory effect of NOC5 addition on processes ofburst 
Cu 2+ induced TBARS formation in LDL. Alter 20 ml of LDL 
(0.25 mg/ml in PBS-EDTA) solution was incubated with 5 gM 
CuSO4, a 2.0 ml aliquot was removed and the remaining solution 
was further incubated to measure TBARS formation. To the re- 
moved aliquot, 10 gmol of NOC5 was added (final concentration 
5 gM NOCh) and the TBARS formation was further measured as 
shown. The process was repeated 5 times every 20 min. TBARS for- 
mation was measured as described in Section 2. 
might be involved as stimulators of LDL oxidation. On the 
other hand, macrophages stimulated by interferon- 7 and tu- 
mor necrosis factor-m, which increased NO generation, were 
reported to depress LDL oxidation [13-15]. The mechanism 
underlying the suppressive activity of NO was suggested to be 
as follows [14]. (1) NO affects the activity of a number of 
heme and iron-sulfur enzymes uch as guanylate cyclase, sev- 
eral enzymes of respiratory metabolism and lipoxygenase. (2) 
NO forms stable chelates with inorganic iron, suggesting that 
NO secretion could lead to changes in the ability of the cul- 
ture medium to support lipid oxidation. NO might act in a 
similar way on intracellular stores of iron and other transition 
metals. 
We used a cell free experimental system and zwitterionic 
polyamine/NO adducts, which release NO and amine by de- 
composing by themselves and do not generate any other rad- 
icals [16]. Therefore, we need not consider the effect of NO on 
the above mentioned enzymes. Sufficient amounts of Cu 2+ (5- 
15 gM) did not change the inhibitory effect of 5 gM NOC5 
(data not shown). The facts indicate that chelating activity of 
NO with Cu 2+ is not essential for the inhibitory effect. In our 
experiments, EDTA was used during the isolation procedure 
and in the reaction system. However, the participation of 
contaminating trace amounts of transition metals such as 
iron is not completely overlooked but may not be essential. 
As NO is a weak reducing agent [12,23], it has the possibility 
to react with related free radicals to reduce and inhibit the 
peroxidative chain reaction. Further studies to clarify the sup- 
pressive activity of NO on Cu 2÷ induced lipid peroxidation 
need to be done. 
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